Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance

Bibliographic Details
Title: Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance
Authors: Rashmi Bangarh, Reena V. Saini, Adesh K. Saini, Tejveer Singh, Hemant Joshi, Seema Ramniwas, Moyad Shahwan, Hardeep Singh Tuli
Source: Cancer Pathogenesis and Therapy, Vol 3, Iss 2, Pp 120-128 (2025)
Publisher Information: Elsevier, 2025.
Publication Year: 2025
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Epithelial–mesenchymal transition, Tumor microenvironment, Metastasis, Cancer drug resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Epithelial–mesenchymal transition (EMT) promotes several cancers by increasing tumor cell motility, disrupting epithelial cell phenotypes, apical–basal polarity, and intracellular connections, and enhancing tumor resistance to immunotherapy and chemotherapy. Mesenchymal–epithelial transition (MET), the opposite of EMT, causes tumor metastasis. EMT drives primary tumor cells, whereas MET inhibits them. Importantly, the complex network of EMT includes cell–cell interactions in the tumor microenvironment. Transcription factors, post-translational regulation, cytokine-mediated signaling, and microRNAs control EMT. In this review, we discussed how molecular mechanisms, signaling networks, and epithelial/mesenchymal states affect cancer treatment resistance and the tumor microenvironment. Research on immunotherapy and chemotherapy problems associated with EMT suggests that targeting EMT might be a potential cancer treatment resistance strategy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2949-7132
Relation: http://www.sciencedirect.com/science/article/pii/S2949713224000533; https://doaj.org/toc/2949-7132
DOI: 10.1016/j.cpt.2024.07.002
Access URL: https://doaj.org/article/6f52aa7ae6e342fea475d6c2ce1e7308
Accession Number: edsdoj.6f52aa7ae6e342fea475d6c2ce1e7308
Database: Directory of Open Access Journals
More Details
ISSN:29497132
DOI:10.1016/j.cpt.2024.07.002
Published in:Cancer Pathogenesis and Therapy
Language:English